ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis

Hu, Chonghui; Xia, Renpeng; Zhang, Xiang; Li, Tingting; Ye, Yuancheng; Li, Guolin; He, Rihua; Li, Zhihua; Lin, Qing*; Zheng, Shangyou*; Chen, Rufu*广东省人民医院; 广东省心血管病研究所; 南方医科大学; 中山大学; 6
Molecular Cancer2022-1-19DOI: 10.1186/s12943-022-01501-3
57被引5阅读
引用收藏
分享

摘要

Background Cancer-associated fibroblasts (CAFs) are critically involved in gemcitabine (GEM) resistance in pancreatic ductal adenocarcinoma (PDAC). However, the underlying mechanism by which CAFs promote chemotherapy resistance remains unexplored. Here, we explored the role of circRNAs in CAF-induced GEM resistance in PDAC. Methods circRNA sequencing and quantitative real-time PCR (qRT-PCR) were utilized to screen CAF-specific circRNAs. The effects of CAF circFARP1 expression on GEM resistance in tumor cells were assessed in vitro and in vivo. RNA-seq, RNA pulldown, RNA immunoprecipitation, and luciferase reporter assays were used to screen the downstream target and underlying mechanism of circFARP1. Results circFARP1 (hsa_circ_0002557), a CAF-specific circRNA, was positively correlated with GEM chemoresistance and poor survival in an advanced PDAC cohort. Silencing or overexpressing circFARP1 in CAFs altered the ability of CAFs to induce tumor cell stemness and GEM resistance via leukemia inhibitory factor (LIF). Mechanistically, we found that circFARP1 directly binds with caveolin 1 (CAV1) and blocks the interaction of CAV1 and the E3 ubiquitin-protein ligase zinc and ring finger 1 (ZNRF1) to inhibit CAV1 degradation, which enhances LIF secretion. In addition, circFARP1 upregulated LIF expression by sponging miR-660-3p. Moreover, high circFARP1 levels were positively correlated with elevated serum LIF levels in PDAC and poor patient survival. Decreasing circFARP1 levels and neutralizing LIF significantly suppressed PDAC growth and GEM resistance in patient-derived xenograft models. Conclusions The circFARP1/CAV1/miR-660-3p/LIF axis is critical for CAF-induced GEM resistance in PDAC. Hence, circFARP1 may be a potential therapeutic target for PDAC.

学科与关键词

关键词
PDACCAFsChemoresistancecircRNAsLIF
相关
加载中…
  • circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway
    Zheng, Shangyou; Hu, Chonghui; Lin, Hongcao; Li, Guolin; Xia, Renpeng; Zhang, Xiang; Su, Dan; Li, Zhihua*; Zhou, Quanbo*; Chen, Rufu*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41(1): 71.被引 23
  • Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
    Zhang, Xiang; Zheng, Shangyou; Hu, Chonghui; Li, Guolin; Lin, Hongcao; Xia, Renpeng; Ye, Yuancheng; He, Rihua; Li, Zhihua; Lin, Qing*; Chen, Rufu*; Zhou, Quanbo*Oncogene, 2022, 41(16): 2372-2389.被引 22
  • Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer
    Zheng, Shangyou; Tian, Qing; Yuan, Yuan; Sun, Shuxin; Li, Tingting; Xia, Renpeng; He, Rihua; Luo, Yuming; Lin, Qing; Fu, Zhiqiang; Zhou, Yu*; Chen, Rufu*; Hu, Chonghui*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42(1): 324.
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Cancer
发表日期
2022-01-19
卷期
第 21 卷, 第 1 期
页码
24
DOI
10.1186/s12943-022-01501-3
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81871945, 82072639, 81802419]; Guangdong Science and Technology Department [2021A1515011089]; National Key R&D Program of China [2017YFC1308600]; Special Fund of "Dengfeng Plan" of Guangdong Provincial People's Hospital, China [KJ012019509, DFJH2020027]

作者

  • H

    Hu, Chonghui (第一作者)

    guangdong prov peoples hosp · guangdong cardiovasc inst

  • X

    Xia, Renpeng

    hunan childrens hosp · 2 · southern med univ · guangdong prov peoples hosp

查看全部 11 位作者收起作者
  • Z

    Zhang, Xiang

    sun yat sen univ

  • L

    Li, Tingting

  • Y

    Ye, Yuancheng

    2 · southern med univ · guangdong prov peoples hosp

  • L

    Li, Guolin

    6 · sun yat sen univ

  • H

    He, Rihua

    guangdong prov peoples hosp

  • L

    Li, Zhihua

    sun yat sen univ

  • L

    Lin, Qing (通讯)

    guangdong prov peoples hosp

  • Z

    Zheng, Shangyou (通讯)

    guangdong prov peoples hosp

  • C

    Chen, Rufu (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417